Validation Methodology & Replication Guide

This report presents a detailed methodology for conducting standardized comparative analyses of AI-generated peer reviews against actual journal peer reviews. The study analyzed five manuscripts submitted to The BMJ between 2021 and 2023, comparing reviews from PeerGenius.ai (an AI-powered peer review platform) with the original human expert reviews. The methodology employs a 10-dimensional scoring framework, issue detection analysis, and critical issue tracking to provide a comprehensive assessment of AI performance. This document serves as a complete replication guide, including all formulas, scoring rubrics, data collection procedures, and analysis steps. The comparison was conducted using Manus.im, an autonomous AI agent platform, with AI reviews generated by PeerGenius.ai's Premier Review tier. The BMJ was selected due to its unique open peer review policy, which provides public access to the complete peer review history, including the original submitted manuscripts. All five selected manuscripts were published under a CC-BY license, which is more permissive than the standard CC-BY-NC license used for most BMJ articles, ensuring full legal compliance for this research.

1.1. Background and Rationale

The peer review process is a cornerstone of scientific publishing, serving as the primary mechanism for quality control and validation of research findings. However, traditional peer review faces numerous challenges, including delays, inconsistency, bias, and the increasing burden on volunteer reviewers. Recent advances in artificial intelligence, particularly large language models (LLMs), have created new opportunities to augment or enhance the peer review process.

This study was designed to rigorously evaluate the performance of an AI-powered peer review system (PeerGenius.ai) against the established benchmark of human expert review at a prestigious medical journal (The BMJ). The objective was to determine whether AI has achieved parity with human reviewers, identify complementary strengths and weaknesses, and provide evidence-based recommendations for the development of hybrid human-AI peer review systems.

1.2. Research Questions

1. Has AI achieved parity with human expert peer review in terms of overall quality?
2. What are the complementary strengths and weaknesses of AI vs. human review?
3. What critical issues does AI catch that human reviewers miss, and vice versa?
4. What is the degree of complementarity between AI and human reviews?
5. What are the implications for the design of hybrid peer review systems?

1.3. Study Design

This was a retrospective comparative analysis of five manuscripts submitted to The BMJ. For each manuscript, we compared the AI-generated review (from PeerGenius.ai) with the original journal peer review (from The BMJ's human expert reviewers). Both reviews evaluated the exact same version of the manuscript (the initial submission, pre-revision), ensuring a fair and direct comparison.

2.1. AI Peer Review Platform: PeerGenius.ai

2.1.1. Platform Overview

• Platform: PeerGenius.ai
• Service: AI-powered manuscript peer review
• Tier Used: Premier Review ($29.99 per manuscript at time of study; pricing now varies by manuscript length)
• Review Time: Minutes (typically 5–15 minutes per manuscript)
• Output: Comprehensive peer review report with editorial decision letter (PDF export)

2.1.2. Multi-Agent Architecture

PeerGenius.ai's Premier Review employs a sophisticated multi-agent system consisting of seven specialized AI reviewers and one Editor-in-Chief. Each agent is powered by a frontier large language model and serves a distinct function in the review process. This architecture is designed to replicate the diversity of perspectives typically found in a multi-reviewer journal peer review process.

The Seven Specialized Reviewers:

1. Domain Expert — Field-specific expertise and novelty assessment. Evaluates the manuscript's contribution to the field, identifies literature gaps, assesses novelty, and ensures domain-specific accuracy.
2. Adversarial Skeptic — Challenge assumptions and identify weaknesses. Stress-tests the methodology by identifying potential weaknesses, questioning assumptions, and exploring alternative explanations.
3. Statistical Methods Agent — Deep statistical analysis with corrective code. Provides in-depth analysis of statistical approaches, identifies issues with test selection or interpretation, and provides corrective code with sample write-ups showing the proper analysis.
4. Results Accuracy Verification Agent — Numerical verification and consistency checking. Verifies calculations, checks data consistency across tables and figures, and flags potential errors.
5. Systematic Reviewer — Methodology, structure, and reporting standards. Ensures research design, statistical methods, and reporting meet publication standards; checks adherence to guidelines (e.g., CONSORT, PRISMA, TRIPOD).
6. Pragmatic Reviewer — Real-world applicability and clarity. Assesses clarity, practical significance, and accessibility for broader audiences.
7. Scientific & Technical Writer — Technical writing and style refinement. Improves scientific clarity, grammar, terminology consistency, and adherence to style guidelines.

Editor-in-Chief — Synthesizes all reviewer feedback into a comprehensive editorial decision letter, weighs different perspectives, and provides clear guidance on revisions.

2.1.3. Review Process

1. Manuscript is uploaded to PeerGenius.ai platform
2. All seven specialized reviewers analyze the manuscript in parallel
3. Each reviewer generates detailed feedback from their specialized perspective
4. Editor-in-Chief synthesizes all feedback into a comprehensive editorial decision letter
5. Complete review report is generated and exported as PDF

2.1.4. Key Features

• Unbiased Feedback: Objective analysis based on academic standards, free from human cognitive biases
• Multiple Perspectives: Each reviewer powered by different frontier models, ensuring diverse viewpoints
• Actionable Feedback: Provides statistical corrective code, methodology fixes, and clarity improvements
• Rapid Turnaround: Complete review in minutes rather than weeks
• Consistency: Applies the same rigorous standards to every manuscript

2.2. Journal Peer Review Source: The BMJ

2.2.1. Journal Overview

• Journal: The British Medical Journal (BMJ)
• Impact Factor: High (varies by year, typically 30–40)
• Acceptance Rate: Selective (approximately 7–10%)
• Peer Review Model: Open peer review (for most article types)
• Specialty: General medicine and public health

2.2.2. Open Peer Review Policy

The BMJ operates an open peer review system for many of its article types, which makes it uniquely suitable for comparative studies of peer review quality. Under this policy:

1. Reviewers are required to sign reviews with their name, position, and institution
2. Competing interests must be declared
3. Reviews are published online alongside the original submitted manuscript (pre-revision), all rounds of reviewer comments, author responses, revised manuscript versions, and the final published version

2.2.3. Why The BMJ Was Selected

1. Complete Transparency: The BMJ's open peer review policy provides public access to the entire peer review history, including the original submitted manuscript. This ensures both AI and human reviewers evaluated the exact same version.
2. High Quality: The BMJ is a prestigious, high-impact journal with rigorous peer review standards. Reviewers are typically experts in their fields.
3. Methodological Diversity: The BMJ publishes a wide range of study designs, allowing for robust assessment across different types of clinical research.
4. Public Accessibility: All materials needed for this study are publicly available, making the study fully transparent and replicable.
5. Ethical Considerations: Because the peer review history is already public, there are no ethical concerns about confidentiality or consent.

2.2.4. Peer Review Process at The BMJ

1. Manuscript submitted by authors
2. Initial editorial screening
3. Manuscript sent to 2–4 expert reviewers
4. Reviewers provide detailed comments and recommendations
5. Editorial committee makes decision (accept, revise, reject)
6. If revisions requested, authors respond and resubmit
7. Revised manuscript may be sent back to reviewers
8. Final editorial decision
9. If accepted, full peer review history published online

2.3. Manuscript Selection and Characteristics

2.3.1. Selection Criteria

1. Public Availability: Full peer review history publicly available on The BMJ website
2. Temporal Range: Submitted between 2021–2023 (recent research)
3. Methodological Diversity: Represents a range of study designs
4. Clinical Relevance: Addresses important public health questions
5. Complete Documentation: All necessary materials available (submitted manuscript, reviews, editorial decisions)

2.3.2. Manuscript Details

Manuscript 1: Hippisley-Cox et al. (2022)

• Full Title: QCovid 4 — Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England
• Study Design: Prediction model development and validation
• Population: Adults testing positive for SARS-CoV-2 in England during the Omicron wave
• Methods: Cox proportional hazards model, external validation
• Reporting Guidelines: TRIPOD

Manuscript 2: Mok et al. (2024)

• Full Title: Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study
• Study Design: Pharmacoepidemiology cohort study
• Population: Patients with dementia
• Methods: Time-varying exposure analysis, propensity score matching
• Key Challenges: Time-varying confounding, multiple outcomes, heterogeneous exposure definitions

Manuscript 3: Morales et al. (2023)

• Full Title: Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis
• Study Design: Interrupted time series analysis
• Intervention: Removal of Quality and Outcomes Framework (QOF) indicators
• Methods: Segmented regression, controlled interrupted time series
• Key Challenges: Autocorrelation, limited pre/post time points, confounding by secular trends

Manuscript 4: Rees et al. (2022)

• Full Title: Serious adverse event rates and reoperation after arthroscopic shoulder surgery: population based cohort study
• Study Design: Cohort study
• Population: Patients undergoing arthroscopic shoulder surgery
• Methods: Descriptive analysis, temporal trends
• Key Challenges: Heterogeneous patient populations, multiple outcomes, temporal confounding

Manuscript 5: Woolf et al. (2023)

• Full Title: A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study
• Study Design: Mendelian randomization study
• Methods: Two-sample Mendelian randomization, sensitivity analyses
• Special Context: BMJ Christmas article (intended to be entertaining and educational)
• Key Challenges: Sample overlap, genetic proxy validity, causal inference limitations

2.4. Licensing Information

All five manuscripts selected for this study were published under the Creative Commons Attribution (CC-BY) license. This is a critical detail, as it provides the legal basis for using these manuscripts in this research, including processing them with an AI system. The CC-BY license is more permissive than the CC-BY-NC (Non-Commercial) license under which most BMJ articles are published. The CC-BY license allows for unrestricted reuse, redistribution, and modification, for both commercial and non-commercial purposes, as long as appropriate attribution is given.

• Legal Compliance: The CC-BY license ensures full compliance with copyright law for the use of these manuscripts in this AI evaluation study.
• Reproducibility: Other researchers can freely access and use the same manuscripts to replicate this study without copyright concerns.
• Transparency: The open access nature of these articles ensures that all materials used in this study are publicly available and verifiable.

2.5. Analysis Platform: Manus.im

• Platform: Manus.im
• Service: Autonomous AI agent for complex task execution
• Model: Advanced LLM with tool use capabilities

The entire comparative analysis was conducted within the Manus.im platform. A detailed prompt (see Appendix A) was provided to the Manus agent, which then autonomously executed the analysis, including: reading and extracting content from both review documents, applying the 10-dimensional scoring framework, categorizing all identified issues, tracking critical issues, generating structured data files (CSV/JSON), creating comprehensive visualizations, and writing detailed analysis reports.

The analytical framework consists of three main components: (1) dimensional scoring, (2) issue detection analysis, and (3) critical issue tracking. Each component is described in detail below, including all formulas and scoring rubrics.

3.1. Dimensional Scoring Framework

Both the AI and journal reviews were evaluated across ten standardized dimensions on a 0–10 scale. The framework was designed to capture both the technical rigor and the practical utility of peer review feedback.

3.1.1. The Ten Dimensions

1. Statistical Rigor

• Definition: The review's ability to identify statistical flaws, assess the appropriateness of statistical methods, and ensure proper application of statistical principles.
• Evaluation Criteria: Identification of multiple testing issues; assessment of power analysis and sample size justification; evaluation of statistical assumptions (e.g., proportional hazards, normality); detection of inappropriate statistical methods; verification of statistical calculations.

Scoring Rubric:

• 9–10: Comprehensive statistical review with identification of all major flaws
• 7–8: Good statistical review with most major issues identified
• 5–6: Adequate statistical review with some issues identified
• 3–4: Limited statistical review with major issues missed
• 0–2: Minimal or no statistical review

2. Methodological Standards

• Definition: The review's enforcement of methodological rigor and adherence to reporting guidelines.
• Evaluation Criteria: Enforcement of discipline-specific reporting guidelines (e.g., CONSORT, STROBE, TRIPOD, PRISMA); assessment of methods completeness and reproducibility; evaluation of study design appropriateness; identification of methodological gaps.

Scoring Rubric:

• 9–10: Rigorous enforcement of methodological standards with comprehensive checklist
• 7–8: Good methodological review with most standards enforced
• 5–6: Adequate methodological review with some standards enforced
• 3–4: Limited methodological review with major gaps
• 0–2: Minimal or no methodological review

3. Clinical/Domain Context

• Definition: The review's demonstration of field-specific knowledge and understanding of clinical or domain-specific implications.
• Evaluation Criteria: Evidence of deep domain expertise; clinical interpretation of findings; understanding of real-world practice implications; identification of clinically meaningful vs. statistically significant findings; contextualization within the existing literature.

Scoring Rubric:

• 9–10: Exceptional domain expertise with nuanced clinical insights
• 7–8: Strong domain knowledge with good clinical interpretation
• 5–6: Adequate domain knowledge with basic clinical understanding
• 3–4: Limited domain knowledge with superficial clinical interpretation
• 0–2: Minimal or no domain-specific insights

4. Study Design Critique

• Definition: The review's evaluation of the appropriateness and rigor of the study design.
• Evaluation Criteria: Assessment of design appropriateness for research question; identification of confounding variables; evaluation of bias (selection, information, measurement); assessment of generalizability and external validity; critique of causal inference claims.

Scoring Rubric:

• 9–10: Comprehensive design critique with identification of all major limitations
• 7–8: Good design critique with most major issues identified
• 5–6: Adequate design critique with some issues identified
• 3–4: Limited design critique with major issues missed
• 0–2: Minimal or no design critique

5. Data Quality & Verification

• Definition: The review's ability to detect numerical errors, inconsistencies, and data quality issues.
• Evaluation Criteria: Detection of numerical errors or impossibilities; identification of inconsistencies across tables, figures, and text; verification of calculations; assessment of missing data handling; evaluation of data quality and completeness.

Scoring Rubric:

• 9–10: Systematic verification with identification of all major errors
• 7–8: Good verification with most major errors identified
• 5–6: Adequate verification with some errors identified
• 3–4: Limited verification with major errors missed
• 0–2: Minimal or no verification

6. Interpretive Depth

• Definition: The review's evaluation of the interpretation and conclusions, including identification of over-reaching claims.
• Evaluation Criteria: Assessment of whether conclusions are supported by data; identification of over-reaching or unjustified claims; evaluation of causality claims; assessment of alternative explanations; nuanced interpretation of findings.

Scoring Rubric:

• 9–10: Sophisticated interpretive analysis with nuanced insights
• 7–8: Strong interpretive analysis with good critical evaluation
• 5–6: Adequate interpretive analysis with basic evaluation
• 3–4: Limited interpretive analysis with superficial evaluation
• 0–2: Minimal or no interpretive analysis

7. Systematic Completeness

• Definition: The review's comprehensive coverage of all manuscript sections and thoroughness.
• Evaluation Criteria: Coverage of all manuscript sections (abstract, introduction, methods, results, discussion); thoroughness of review; identification of gaps or omissions; systematic approach to review.

Scoring Rubric:

• 9–10: Comprehensive coverage of all sections with no gaps
• 7–8: Good coverage with most sections reviewed thoroughly
• 5–6: Adequate coverage with some sections reviewed
• 3–4: Limited coverage with major sections missed
• 0–2: Minimal or no systematic coverage

8. Actionability & Structure

• Definition: The clarity, organization, and specificity of the feedback provided.
• Evaluation Criteria: Clarity of feedback; organization (e.g., required/recommended/optional); specificity of recommendations; prioritization of issues; ease of implementation.

Scoring Rubric:

• 9–10: Highly structured, clear, and actionable feedback
• 7–8: Well-structured and mostly actionable feedback
• 5–6: Adequately structured with some actionable feedback
• 3–4: Poorly structured with limited actionability
• 0–2: Unstructured and not actionable

9. Tone & Constructiveness

• Definition: The balance of criticism and encouragement, and the professionalism of the review.
• Evaluation Criteria: Balance of positive and negative feedback; constructiveness of criticism; professionalism and respect; encouragement and support; avoidance of personal attacks or dismissiveness.

Scoring Rubric:

• 9–10: Exceptionally balanced, constructive, and professional
• 7–8: Well-balanced and constructive
• 5–6: Adequately balanced with some constructiveness
• 3–4: Imbalanced or overly critical
• 0–2: Unprofessional or dismissive

10. Editorial Judgment

• Definition: The appropriateness of the editorial decision and calibration of severity.
• Evaluation Criteria: Appropriateness of decision (accept/revise/reject); calibration of severity (minor vs. major revisions); consistency between feedback and decision; recognition of manuscript strengths and weaknesses.

Scoring Rubric:

• 9–10: Excellent editorial judgment, perfectly calibrated
• 7–8: Good editorial judgment, well-calibrated
• 5–6: Adequate editorial judgment, reasonably calibrated
• 3–4: Poor editorial judgment, poorly calibrated
• 0–2: Inappropriate or inconsistent editorial judgment

3.1.2. Overall Quality Score Calculation

The Overall Quality Score is calculated as the arithmetic mean of all ten dimensional scores:

Where:

• Σ Dimensional Scores = Sum of scores for all 10 dimensions
• Each dimensional score ranges from 0 to 10

Quality Rating Categories:

• 9.0–10.0: Outstanding
• 8.0–8.9: Excellent
• 7.0–7.9: Good
• 6.0–6.9: Adequate
• Below 6.0: Fair/Poor

3.1.3. Parity Assessment

Parity is defined as achieving an overall quality score within 1.0 point of the comparator. This threshold was chosen to represent meaningful equivalence while allowing for minor differences.

Where:

• AI Score = Overall Quality Score for AI review
• Journal Score = Overall Quality Score for journal review
• | | denotes absolute value

3.2. Issue Detection Analysis

All unique issues identified in both reviews were systematically categorized to assess the degree of overlap and complementarity between the AI and human approaches.

3.2.1. Issue Categorization

Each unique issue was categorized into one of three mutually exclusive categories:

1. Convergence (Both): Issues identified by both the AI and journal reviews
2. Journal Only: Issues identified only by the journal review
3. AI Only: Issues identified only by the AI review

Operational Definition of “Same Issue”: Two issues were considered the “same” if they referred to the same specific problem, even if expressed differently. For example, “multiple testing correction not applied” and “no adjustment for multiple comparisons” would be considered the same issue.

3.2.2. Complementarity Score Calculation

The Complementarity Score quantifies the degree to which the two reviews identified different sets of issues. A higher score indicates greater complementarity (i.e., the reviews are more synergistic and less redundant).

Where:

• N_Journal_Only = Number of issues identified only by the journal review
• N_AI_Only = Number of issues identified only by the AI review
• N_Total_Unique = Total number of unique issues across both reviews
• N_Total_Unique = N_Journal_Only + N_AI_Only + N_Both

Interpretation:

• 70–100%: Very high complementarity (reviews catch very different issues)
• 50–69%: High complementarity (substantial differences)
• 30–49%: Moderate complementarity (some overlap)
• Below 30%: Low complementarity (high overlap, redundant reviews)

Example Calculation:

Suppose a comparison yields:

• Journal Only: 14 issues
• AI Only: 10 issues
• Both: 6 issues
• Total Unique: 14 + 10 + 6 = 30 issues

This would be interpreted as “very high complementarity,” indicating that the two reviews identified substantially different sets of issues and are highly synergistic.

3.3. Critical Issue Tracking

Critical issues were defined as those that could fundamentally invalidate the study's findings or conclusions. These were tracked separately to assess the ability of each review to identify the most serious methodological or statistical flaws.

3.3.1. Critical Issue Categories

1. Statistical Flaws: Errors or omissions in statistical methods that could lead to invalid inferences (e.g., multiple testing without correction, violation of statistical assumptions, inadequate power)
2. Data Quality Errors: Numerical impossibilities, inconsistencies, or errors that undermine data integrity (e.g., impossible confidence intervals, inconsistent numbers across tables)
3. Methodological Gaps: Missing or incomplete methodological information that prevents reproducibility or assessment of validity
4. Design Limitations: Fundamental flaws in study design that threaten internal or external validity (e.g., uncontrolled confounding, severe selection bias)
5. Interpretive Issues: Over-reaching conclusions or causal claims not supported by the study design

3.3.2. Critical Issue Detection Matrix

For each manuscript, a binary matrix was created to track which critical issues were detected by each review:

From this matrix, we calculated:

• Total Critical Issues Detected by Journal: Sum of “Yes” in Journal column
• Total Critical Issues Detected by AI: Sum of “Yes” in AI column
• Critical Issues Detected by Both: Count of rows where both columns are “Yes”
• Critical Issues Missed by Both: Count of rows where both columns are “No”

4.1. Obtaining Journal Peer Reviews from The BMJ

4.1.1. Accessing Peer Review History

For each manuscript, the peer review history was accessed through The BMJ's website:

1. Navigate to the published article on The BMJ website
2. Locate the “Peer review” or “History” tab/link
3. Download the peer review history PDF, which includes: original submitted manuscript, all reviewer comments (first round), author responses, revised manuscript (if applicable), subsequent review rounds, and editorial decision letters

4.1.2. Extracting Reviewer Comments

From the peer review history PDF, the following information was extracted for each reviewer:

• Reviewer number/identifier
• Reviewer's overall recommendation (accept/revise/reject)
• Reviewer's detailed comments
• Specific issues identified
• Suggestions for improvement
• Editorial committee comments (if applicable)

4.2. Generating AI Reviews with PeerGenius.ai

4.2.1. Manuscript Preparation

For each manuscript, the original submitted version (pre-revision) was obtained from The BMJ's peer review history. This ensured that the AI reviewed the exact same version that the human reviewers evaluated.

4.2.2. Review Generation Process

1. Navigate to PeerGenius.ai
2. Select “Premier Review” tier ($29.99 at time of study)
3. Upload the original submitted manuscript (PDF)
4. Wait for review generation (typically 5–15 minutes)
5. Download the complete review report (PDF)

4.2.3. AI Review Components

The AI review included:

• Individual reviews from all 7 specialized agents
• Editor-in-Chief's consolidated editorial decision letter
• Overall recommendation (accept/revise/reject)
• Structured feedback (required/recommended/optional)
• Specific issues identified by each agent
• Suggestions for improvement

4.3. Data Extraction and Coding

4.3.1. Review Reading and Note-Taking

For each review (both AI and journal), a comprehensive set of notes was created, including:

• All issues identified
• Severity of each issue (critical/major/minor)
• Category of each issue (statistical/methodological/clinical/etc.)
• Specific quotes supporting each issue
• Overall tone and constructiveness
• Editorial decision and justification

4.3.2. Issue Extraction

All unique issues were extracted from both reviews and compiled into a master list. Each issue was coded with:

• Issue Description: Brief description of the problem
• Category: Statistical/Methodological/Clinical/Design/Interpretive/Data Quality/Other
• Severity: Critical/Major/Minor
• Source: Journal/AI/Both
• Evidence: Specific quote or reference from the review

5.1. Step-by-Step Analysis Process

The analysis was conducted in seven sequential steps:

Step 1: Document Review

• Read both the AI and journal review documents thoroughly
• Extract all issues, concerns, and recommendations from each
• Note the editorial decision from each review
• Create comprehensive notes for each review

Step 2: Dimensional Scoring

• Apply the 10-dimensional framework to each review independently
• Document specific evidence supporting each score
• Assign scores (0–10) for each dimension
• Calculate overall quality scores
• Determine if parity was achieved

Step 3: Issue Categorization

• Create a master list of all unique issues identified across both reviews
• Categorize each issue as: Both, Journal Only, or AI Only
• Classify severity: Critical, Major, Minor
• Calculate complementarity score

Step 4: Critical Issue Analysis

• Identify which critical issues each review caught
• Determine if detection was explicit, implied, or absent
• Assess impact on manuscript validity
• Create critical issue detection matrix

Step 5: Data Export

• Generate all CSV/JSON files with structured data
• Ensure data is machine-readable for future analysis
• Export dimensional scores, issue categorizations, and critical issue matrix

Step 6: Visualization

• Create comprehensive multi-panel figure
• Include key findings summary box
• Ensure all panels are clearly labeled
• Use consistent color scheme (Blue for Journal, Green for AI)

Step 7: Report Writing

• Write executive summary highlighting main findings
• Provide detailed analysis of each dimension
• Generate actionable recommendations
• Synthesize findings across all manuscripts

5.2. Quality Control Procedures

1. Consistency Checks: All manuscripts were analyzed using the exact same framework and scoring criteria
2. Evidence Documentation: All scores were supported by specific quotes and examples from the reviews
3. Double-Checking: Critical issues and dimensional scores were reviewed multiple times to ensure accuracy
4. Transparency: All data, scores, and evidence were exported to structured files for independent verification

For each manuscript, the analysis generated the following deliverables:

6.1. Comprehensive Visualization (PNG)

A multi-panel figure (typically 7–8 panels) including:

1. Panel 1: Overall Quality Scores (bar chart)
2. Panel 2: Dimensional Performance Comparison (grouped bar chart)
3. Panel 3: Issue Detection Overlap (bar chart)
4. Panel 4: Critical Issues Detection (grouped bar chart)
5. Panel 5: Review Characteristics Profile (radar chart)
6. Panel 6: Complementarity Score (circular badge or bar)
7. Panel 7: Key Findings Box (text summary)

6.2. Data Export Files

1. dimensional_scores.csv: All 10 dimensional scores for both reviews
2. issue_detection.json: Complete issue categorization with metadata
3. critical_issues.csv: Critical issue detection matrix

6.3. Detailed Analysis Documents (Markdown)

1. standardized_scores.md: Complete dimensional analysis with evidence
2. issue_breakdown.md: Comprehensive list of all issues
3. comparison_report.md: Executive summary and strategic recommendations
4. summary_table.md: Quick reference comparison table

6.4. Cross-Study Synthesis

After analyzing all five manuscripts, a cross-study synthesis was generated, including:

1. Synthesis Visualization: Multi-panel figure showing aggregate results across all manuscripts
2. Synthesis Report: Comprehensive report summarizing patterns and implications
3. Aggregate Data: CSV file with summary statistics for all manuscripts

7.1. Methodological Limitations

1. Sample Size: Only five manuscripts were analyzed, which may limit generalizability
2. Journal Selection: Only The BMJ was used; results may not generalize to other journals
3. Study Design Diversity: While diverse, the five manuscripts may not represent all types of clinical research
4. Temporal Factors: Manuscripts span 2021–2023; AI capabilities have evolved rapidly
5. Subjective Scoring: Dimensional scoring involves subjective judgment, despite the use of rubrics

7.2. Considerations for Replication

Researchers seeking to replicate this study should consider:

1. AI Evolution: AI capabilities are rapidly improving; results may differ with newer AI models
2. Journal Policies: Not all journals have open peer review policies; access to materials may be limited
3. Cost: PeerGenius.ai Premier Review pricing varies by manuscript length (was $29.99 at time of study); budget accordingly
4. Expertise: Dimensional scoring requires expertise in research methodology and statistics

8.1. Use of Public Data

All materials used in this study (journal peer reviews and submitted manuscripts) were obtained from publicly available sources (The BMJ's open peer review history). No confidential or proprietary information was used.

8.2. Transparency

This methodology report provides complete transparency about all procedures, formulas, and decision rules, enabling full replication by other researchers.

8.3. Potential Conflicts of Interest

Researchers conducting similar studies should disclose any financial or professional relationships with AI peer review platforms or journals.

This methodology provides a rigorous, standardized, and replicable framework for comparing AI-generated peer reviews with human expert reviews. The 10-dimensional scoring system, issue detection analysis, and critical issue tracking provide a comprehensive assessment of AI performance. The use of The BMJ's open peer review history ensures that comparisons are fair and direct, as both AI and human reviewers evaluated the exact same manuscript version. This approach can be used by other researchers to evaluate different AI peer review systems, different journals, or different types of research.

1. PeerGenius.ai. (2026). AI-Powered Scientific Peer Reviews. Retrieved from https://peergenius.ai/
2. BMJ. (2026). Peer Review Terms and Conditions. Retrieved from https://authors.bmj.com/policies/peer-review-terms-and-conditions/
3. Hippisley-Cox, J., et al. (2023). Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study. BMJ, 381, e072976.
4. Mok, P. L. H., et al. (2024). Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ, 385, e076268.
5. Morales, D. R., et al. (2023). Estimated impact from the withdrawal of primary care financial incentives on selected indicators of quality of care in Scotland: controlled interrupted time series analysis. BMJ, 380, e072098.
6. Rees, J. L., et al. (2022). Serious adverse event rates and reoperation after arthroscopic shoulder surgery: population based cohort study. BMJ, 378, e069901.
7. Woolf, B., et al. (2023). A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study. BMJ, 383, e076197.

The following prompt was provided to the Manus.im autonomous AI agent to conduct each comparative analysis. Researchers can use this exact prompt to replicate the study with their own manuscripts.

Detailed scoring rubrics for each of the 10 dimensions are provided in Section 3.1.1 above.

Manuscript: Hippisley-Cox et al. (2022)

Journal Only Issues (12):

• Advanced statistical methods (Net Benefit, Decision Curve Analysis)
• Sophisticated interpretive insights
• Nuanced understanding of UK healthcare context
• ... (and 9 more)

AI Only Issues (21):

• Systematic numerical verification (found discrepancies journal missed)
• Explicit multiple testing correction requirement
• Systematic TRIPOD compliance checking
• ... (and 18 more)

Both (Convergence) Issues (9):

• Mismatch between target population and intended use (CRITICAL)
• Need for external validation
• ... (and 7 more)